Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Muscle-Specific Tyrosine Kinase and Myasthenia Gravis Owing to Other Antibodies.

Neurologic clinics - 1 May 2018

Rivner Michael H, Pasnoor Mamatha, Dimachkie Mazen M, Barohn Richard J, Mei Lin

Abstract excerpt

Around 20% of patients with myasthenia gravis are acetylcholine receptor antibody negative; muscle-specific tyrosine kinase antibodies (MuSK) were identified as the cause of myasthenia gravis in 30% to 40% of these cases. Anti MuSK myasthenia gravis is associated with specific clinical phenotypes. One is a bulbar form with fewer ocular symptoms. Others show an isolated head drop or symptoms indistinguishable from...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Autoantibodies
Share to Autoantigens
Share to Myasthenia Gravis

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Neuromuscular Junction

Share to Phenotype

Share to Receptor Protein-Tyrosine Kinases

Share to Receptors, Cholinergic

Source

Open in PubMed Open full text

Identifiers

PMID: 29655451
DOI: 10.1016/j.ncl.2018.01.004
PMCID: PMC6051709

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Muscle-Specific Tyrosine Kinase and Myasthenia Gravis Owing to Other Antibodies.PMID 29655451Read ↗

Different characteristic phenotypes according to antibody in myasthenia gravis.Semantic proximity Read ↗

Pathogenesis of myasthenia gravis: update on disease types, models, and mechanismsSemantic proximity Read ↗

Spotlight on MuSK Positive Myasthenia Gravis: Clinical Characteristics, Treatment and OutcomesSemantic proximity Read ↗

Prevalence, clinical features and treatment outcomes of patients with myasthenia gravis positive for antibodies to muscle-specific kinase in Thailand.Semantic proximity Read ↗

Dilemma on Animal Models for Ocular Myasthenia Gravis: Can Lipoprotein Receptor-related Protein 4 Experimental Autoimmune Myasthenia Gravis Fix This Problem?Semantic proximity Read ↗

[Seronegative myasthenia gravis].Semantic proximity Read ↗

Complement and myasthenia gravisSemantic proximity Read ↗

Neurophysiological and mitochondrial abnormalities in MuSK antibody seropositive myasthenia gravis compared to other immunological subtypesSemantic proximity Read ↗

Phenotype, Severity, and Therapy of Patients With LRP4 Antibody-Associated Myasthenia Gravis in the German Myasthenia Gravis Registry.Semantic proximity Read ↗

Clinical aspects and serodiagnosis of myasthenia gravis in Algerian patients: a prospective study on a small group of patientsSemantic proximity Read ↗

Clinical Features and Diagnostic Usefulness of Antibodies to Clustered Acetylcholine Receptors in the Diagnosis of Seronegative Myasthenia Gravis.Semantic proximity Read ↗

Development and Application of a Cell-Based Assay for LRP4 Antibody Associated With Myasthenia GravisSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.